Skip to main content

Animations

MJFF Publications

1981 - 1990 of 8825 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    RESTRICTED
    Title: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-021-01455-x
    Citation Count: 135
  • Summary Details
    RESTRICTED
    Title: Aducanumab: look before leaping
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-021-01477-5
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson’s Disease
    Journal Name: European Neurology
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1159/000517538
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Advanced Machine Learning Tools to Monitor Biomarkers of Dysphagia: A Wearable Sensor Proof-of-Concept Study
    Journal Name: Digital Biomarkers
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1159/000517144
    Citation Count: 34
  • Summary Details
    RESTRICTED
    Title: Associations of Gait Disorders and Recurrent Falls in Older People: A Prospective Population-Based Study
    Journal Name: Gerontology
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1159/000520959
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Programming Directional Deep Brain Stimulation in Parkinson’s Disease: A Randomized Prospective Trial Comparing Early versus Delayed Stimulation Steering
    Journal Name: Stereotactic and Functional Neurosurgery
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1159/000517054
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Restoration of Noradrenergic Function in Parkinson’s Disease Model Mice
    Journal Name: ASN Neuro
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/17590914211009730
    Citation Count: 14
  • Summary Details
    RESTRICTED
    Title: Biomedical Research Must Change — But a Shift Toward Human-specific Research Methods Is Only Part of What Is Needed
    Journal Name: Alternatives to Laboratory Animals
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1177/02611929211030417
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Amyloid Precursor Protein Variant, E665D, Associated With Unique Clinical and Biomarker Phenotype
    Journal Name: American Journal of Alzheimer's Disease & Other Dementias®
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1177/1533317520981225
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Acceptability and Feasibility of a Mindfulness Intervention Delivered via Videoconferencing for People With Parkinson’s
    Journal Name: Journal of Geriatric Psychiatry and Neurology
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1177/0891988720988901
    Citation Count: 51
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.